Editorial: Clustering of schizophrenia with other comorbidities - What can we learn?

Schizophrenia Bulletin

Volumn 35, Issue 2, 2009, Pages 282-283

  Mitchell, Braxton D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE; NOS1AP ENZYME; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CHROMOSOME 1Q; CLINICAL FEATURE; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; EDITORIAL; ENERGY METABOLISM; ENVIRONMENTAL FACTOR; GENE CLUSTER; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GLUCOSE INTOLERANCE; HUMAN; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SCHIZOPHRENIA; CLUSTER ANALYSIS; DIABETES MELLITUS; GENETICS; PSYCHOLOGY;

CLUSTER ANALYSIS; COMORBIDITY; DIABETES MELLITUS; HUMANS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 65349180460     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn189     Document Type: Editorial

References (14)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Maudsley H. The Pathology of Mind. London, UK: Macmillan; 1879.
3. Holt RI, Peveler RC, Byrne CD. Schizophrenia, the metabolic syndrome and diabetes. Diabet Med. 2004;21:515-523.
4. Holt RI, Bushe C, Citrome L. Diabetes and schizophrenia 2005: are we any closer to understanding the link?J. Psycho-pharmacol. 2005;19:56-65.
5. Fernandez-Egea E, Bernardo M, Parellada E, et al. Glucose abnormalities in the siblings of people with schizophrenia. Schizophr Res. 2008;103:110-113.
6. Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry. 2003;160:284-289.
7. Spelman LM, Walsh PI, Sharifi N, Collins P, Thakore JH. Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia. Diabet Med. 2007;24:481-485.
8. Altar CA, Hunt RA, Jurata LW, et al. Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells. Biol Psychiatry. 2008;64: 1077-1087.
9. Prokopenko I, McCarthy MI, Lindgren CM.: Type 2 diabetes: new genes, new understanding. Trends Genet. 2008;24:613-621.
10. Das SK, Elbein SC. The search for type 2 diabetes susceptibility loci: the chromosome lq story. Curr Diab Rep. 2007;7:154-164.
11. Gough SC, O'donovan MC. Clustering of metabolic comor-bidity in schizophrenia: a genetic contribution?J. Psychophar-macol. 2005;19:47-55.
12. Brzustowicz LM. NOS1AP in schizophrenia. Curr Psychiatry Rep. 2008;10:158-163.
13. Arking DE, Pfeufer A, Post W, et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repo-larization. Nat Genet. 2006;38:644-651.
14. Post W, Shen H, Damcott C, et al. Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the Old Order Amish. Hum Hered. 2007; 64:214-219.